Biocept Inc (BIOC) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BIOC Annual Balance Sheets →
The balance sheet data below highlights changes in Biocept Inc's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2023)
(Mar 31 2023) (Dec 31 2022) (Sep 30 2022) (Jun 30 2022)
Assets
Cash & cash equivalent6.63
Cash & Short-term Investments6.00
Accounts receivable0.80
Inventories0.55
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.88
Total Current Assets8.86
Equipment/Property/Plant Net2.40
Other Assets, Noncurrent2.00
Operating Lease Right Of Use Asset8.19
Finance Lease Right Of Use Asset2.27
Total Assets22.10
Liabilities
Accounts Payable, Current AC1.47
Accrued Liabilities, Current AC1.53
Other Liabilities, Current1.91
Total Current Liabilities4.90
Total Long-term Debt0.00
Other liabilities, Noncurrent16.91
FinanceLeaseLiabilityNoncurrent0.84
Operating Lease Liability Current0.57
Finance Lease Liability Current0.82
Total Liabilities21.81
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock309.50
Retained Earnings / Accumulated Deficit-309.21
Other Equity0.00
Common Stockholder's Equity0.29
Total Stockholder's Equity0.29
Liabilities & Stockholder's Equity22.10
4 historic quarters locked

Sign in to unlock the full Biocept Inc balance sheet history.

About Biocept Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-23-042468

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.